New Metabolic Disease Articles from our Partners at Consultant 360

SGLT2 Inhibitors vs DPP-4 Inhibitors: Which is Tied to Less Renal Risk?

In a recent cohort study, researcher examined the risk of serious renal events associated with the use of sodium-glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors. 

https://www.consultant360.com/endocrinology/diabetes/sglt2-inhibitors-vs-dpp-4-inhibitors-which-tied-less-renal-risk 

Simple Grip Test Could Predict Diabetes Risk

In a recent study, researchers investigated the possibility of using grip strength tests in the screening of patients for type 2 diabetes mellitus.

https://www.consultant360.com/exclusive/endocrinology/diabetes/simple-grip-test-could-predict-diabetes-risk 

Novel Risk Score for Predicting Thrombogenic Milieu in NVAF Is Developed

According to the developers, the new risk score model demonstrated higher accuracy than the CHADS2 and CHA2DS2-VASc score systems.

https://www.consultant360.com/exclusive/cardiology/arrhythmia-ep/novel-risk-score-predicting-thrombogenic-milieu-nvaf-developed 

Can Smartwatches Improve Anticoagulation Therapy Adherence Among Patients With AFib?

Although long-term oral anticoagulation therapy can significantly reduce thromboembolic complications among patients with atrial fibrillation, adherence to therapy can be challenging. Researchers evaluated whether a smartwatch can improve adherence. The findings were shared during Heart Rhythm Society 2020 Science.

https://www.consultant360.com/exclusive/cardiology/arrhythmia-ep/can-smartwatches-improve-anticoagulation-therapy-adherence-among 

USPSTF Recommends That Primary Care Offer Counseling For the Prevention of CVD

The US Preventive Services Task Force has released an update to its 2014 recommendations in the form of a draft statement on the prevention of cardiovascular disease through behavioral counseling.

https://www.consultant360.com/consultant360/primary-care/uspstf-recommends-primary-care-offer-counseling-prevention-cvd